Equifax Inc
NYSE:EFX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
210.74
306.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Equifax Inc
Equifax Inc
Cash Equivalents
Equifax Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Equifax Inc
NYSE:EFX
|
Cash Equivalents
$468.2m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
23%
|
CAGR 10-Years
15%
|
|
|
Booz Allen Hamilton Holding Corp
NYSE:BAH
|
Cash Equivalents
$558.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
9%
|
|
|
TransUnion
NYSE:TRU
|
Cash Equivalents
$643.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
22%
|
CAGR 10-Years
19%
|
|
|
Leidos Holdings Inc
NYSE:LDOS
|
Cash Equivalents
$1.2B
|
CAGR 3-Years
26%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Verisk Analytics Inc
NASDAQ:VRSK
|
Cash Equivalents
$458m
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
|
CoStar Group Inc
NASDAQ:CSGP
|
Cash Equivalents
$4.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
29%
|
CAGR 10-Years
26%
|
|
Equifax Inc
Glance View
Equifax Inc. is a prominent player in the global data analytics and consumer credit reporting industry, often found at the forefront of discussions related to financial stability and identity verification. Founded in 1899 and headquartered in Atlanta, Georgia, Equifax operates in a vital role by helping businesses, lenders, and consumers navigate the complexities of financial information. The company's core services include credit reporting, risk assessment, and fraud prevention, which are crucial for making informed lending decisions. As digital transactions continue to rise and data security becomes increasingly paramount, Equifax has strategically positioned itself to leverage its vast database of consumer credit history, ensuring that it remains relevant in an ever-evolving economic landscape. For investors, Equifax represents both opportunity and caution. The company's significant market share and essential services lend it a competitive edge, making it integral to consumer finance. However, potential investors must be aware of the risks associated with its business model, particularly in light of the massive data breach in 2017, which has prompted ongoing concerns about cybersecurity and regulatory pressures. To address these challenges, Equifax has made substantial investments in technology and compliance initiatives, aiming to restore trust and enhance its operational resilience. As the demand for data-driven insights continues to grow, Equifax has the potential for robust growth, but investors should carefully weigh this opportunity against the inherent risks in the data-centric financial services sector.
See Also
What is Equifax Inc's Cash Equivalents?
Cash Equivalents
468.2m
USD
Based on the financial report for Sep 30, 2024, Equifax Inc's Cash Equivalents amounts to 468.2m USD.
What is Equifax Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
15%
Over the last year, the Cash Equivalents growth was 13%. The average annual Cash Equivalents growth rates for Equifax Inc have been -39% over the past three years , 23% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
